Dawn Hershman, M.D., M.S.

Dr. Dawn Hershman is Assistant Professor of Medicine at the Columbia University College of Physicians and Surgeons in the Division of Medical Oncology and has completed a Masters of Science in Biostatistics with an emphasis on patient-oriented research, at the Mailman School of Public Health.

She received her M.D. from The Albert Einstein College of Medicine, then trained in internal medicine at Columbia Presbyterian Medical Center where she served as Chief Resident, then completed a fellowship in Medical Oncology/Hematology. She is now the Director of the Clinical Breast Oncology Program. She has an interest and expertise in the area of health outcomes research with a specific interest in supportive care, racial disparities, and breast cancer survivorship.

Dr. Hershman has worked on several studies utilizing decision analysis models to determine the effectiveness of chemoprevention for groups of women at high risk of developing breast cancer. And she has published several papers from the linkage of the National Cancer Institute's Surveillance, Epidemiology and End-Result database with the Health Care Finance Administration's database, evaluating the utilization patterns of platinum-based chemotherapy in elderly patients with cancer.

She has several ongoing projects funded by the American Cancer Society evaluating the cognitive effects of chemotherapy. She has also been awarded grants from the American Society of Clinical Oncology and from The National Cancer Institute to support her investigation of bone loss patterns and osteoporosis prevention during treatment of breast cancer.